Hypoadiponectinemia, elevated iron and high-sensitivity C-reactive protein levels and their relation with prostate size in benign prostatic hyperplasia

被引:8
作者
Nandeesha, H. [1 ]
Eldhose, A. [1 ]
Dorairajan, L. N. [1 ]
Anandhi, B. [1 ]
机构
[1] Jawaharlal Inst Postgrad Med Educ & Res, Dept Biochem & Urol, Pondicherry, India
关键词
adiponectin; benign prostatic hyperplasia; C-reactive protein; iron; prostate-specific antigen; SERUM ADIPONECTIN; CANCER; TISSUE; RISK;
D O I
10.1111/and.12715
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Elevated iron, high-sensitivity C-reactive protein (CRP) and hypoadiponectinemia are known to initiate tumour development. There is paucity of data regarding the above-mentioned parameters and their relation with prostate size in benign prostatic hyperplasia (BPH). The present study was designed to assess the levels of iron, hs-CRP and adiponectin levels and their association with prostate size in BPH patients. A total of 37 BPH cases and 36 controls were enrolled in the study. Iron, hs-CRP and adiponectin were estimated in both the groups. Iron and hs-CRP were significantly increased and adiponectin was significantly reduced in BPH cases when compared with controls. Iron (r=.397, p=.015), hs-CRP (r=.341, p=.039) and adiponectin (r=-.464, p=.004) were significantly associated with prostate size in BPH cases. Multivariate linear regression analysis showed that iron acts as predictor of prostate size in BPH (R-2 = 0.395, beta = 0.526, p=.001). We conclude that iron and hs-CRP are elevated and adiponectin is reduced in BPH cases and associated with prostate size.
引用
收藏
页数:3
相关论文
共 15 条
[1]   C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer [J].
Beer, Tomasz M. ;
Lalani, Alshad S. ;
Lee, Stella ;
Mori, Motomi ;
Eilers, Kristine M. ;
Curd, John G. ;
Henner, W. David ;
Ryan, Christopher W. ;
Venner, Peter ;
Ruether, J. Dean ;
Chi, Kim N. .
CANCER, 2008, 112 (11) :2377-2383
[2]   THE DEVELOPMENT OF HUMAN BENIGN PROSTATIC HYPERPLASIA WITH AGE [J].
BERRY, SJ ;
COFFEY, DS ;
WALSH, PC ;
EWING, LL .
JOURNAL OF UROLOGY, 1984, 132 (03) :474-479
[3]   Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: A retrospective analysis [J].
Di Silverio, F ;
Gentile, V ;
De Matteis, A ;
Mariotti, G ;
Giuseppe, V ;
Luigi, PA ;
Sciarra, A .
EUROPEAN UROLOGY, 2003, 43 (02) :164-175
[4]   Prostate cancer and adiponectin [J].
Goktas, S ;
Yilmaz, MI ;
Caglar, K ;
Sonmez, A ;
Kilic, S ;
Bedir, S .
UROLOGY, 2005, 65 (06) :1168-1172
[5]   Association between Trace Element and Heavy Metal Levels in Hair and Nail with Prostate Cancer [J].
Karimi, Golgis ;
Shahar, Suzana ;
Homayouni, Nasim ;
Rajikan, Roslee ;
Abu Bakar, Nor Faizah ;
Othman, Mohd Sham .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (09) :4249-4253
[6]   Adiponectin and cancer: a systematic review [J].
Kelesidis, I ;
Kelesidis, T ;
Mantzoros, C .
BRITISH JOURNAL OF CANCER, 2006, 94 (09) :1221-1225
[7]   The natural history of benign prostatic hyperplasia: What have we learned in the last decade? [J].
Kirby, RS .
UROLOGY, 2000, 56 (5A) :3-6
[8]   High-Sensitivity C-Reactive Protein and Cancer [J].
Lee, Seounghee ;
Choe, Jae-Won ;
Kim, Hong-Kyu ;
Sung, Joohon .
JOURNAL OF EPIDEMIOLOGY, 2011, 21 (03) :161-168
[9]   Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond [J].
Lu, Jin-Ying ;
Huang, Kuo-Chin ;
Chang, Lin-Chau ;
Huang, Ying-Shing ;
Chi, Yu-Chiao ;
Su, Ta-Chan ;
Chen, Chi-Ling ;
Yang, Wei-Shiung .
JOURNAL OF BIOMEDICAL SCIENCE, 2008, 15 (05) :565-576
[10]   Metabolic Syndrome and Liver Cancer: is Excess Iron the Link? [J].
Mascitelli, Luca ;
Goldstein, Mark R. .
HEPATOLOGY, 2011, 54 (04) :1487-1487